dockets: FDA-2004-P-0401
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2004-P-0401 | FDA | Request the Commissioner of Food and Drugs re-evaluate FDA's policy concerning the marketing of 'authorized generic' versions of brand name prescription drugs. - CLOSED | Nonrulemaking | 2021-09-01T01:02:20Z | 0b000064804744cc |
Links from other tables
- 4 rows from docket_id in documents